Skip to main content

  • Sunday, Mar 8th
    1:30 PM - 5:35 PM EST
    Atherosclerosis and Lipids Summit
    Location: Monroe
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    1:30 PM - 1:38 PM EST
    Global Trends in Heart Disease & Targets for Improvement: Statistics & Epidemiology Update from the American Heart Association
    Location: Monroe
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    1:30 PM - 2:45 PM EST
    INSIGHTS INTO THE PATHOPHYSIOLOGY AND MECHANISMS AND IMAGING OF THE ATHEROSCLEROTIC DISEASE
    Location: Monroe
    Moderator: Takashi Akasaka, MD, PhD – Nishinomiya Watanabe Cardiovascular Cerebral Center
    Moderator: Rasha Al-Lamee, MA, MD, PhD – Imperial College London
    Moderator: Renu Virmani, MD – CVPath Institute, Inc.
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    1:38 PM - 1:46 PM EST
    Novel Advances in Identifying the Vulnerable Plaque | Insights from the VPM Meeting
    Location: Monroe
    Speaker: Ramzi Khamis, MB ChB PhD FRCP FESC – Imperial College London and Imperial College Healthcare NHS Trust
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    1:46 PM - 1:54 PM EST
    GLP1 in Cardiometabolic Disease
    Location: Monroe
    Speaker: Charles German, MD, MS, FAHA, FASPC – Georgetown University
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    1:54 PM - 2:02 PM EST
    Lipid Lowering | Persistent Gaps in Implementation
    Location: Monroe
    Speaker: Usman Baber, MD, MS – University of Oklahoma Health Sciences Center
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    2:02 PM - 2:10 PM EST
    AI Based Coronary CT Plaque Detection | Methods and Accuracy
    Location: Monroe
    Speaker: Allen J. Taylor, MD – MedStar Heart and Vascular Institute
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    2:10 PM - 2:18 PM EST
    Impact of Treatment Adherence and Persistence to LDL-C Lowering Therapies on Cardiovascular Events
    Location: Monroe
    Speaker: Robert S. Rosenson, MD – Mount Sinai Health System
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    2:18 PM - 2:26 PM EST
    SMuRF-Less but Inflamed - Risk of Patients Without Standard Modifiable Risk Factors Who Are Inflamed
    Location: Monroe
    Speaker: Paul M. Ridker, MD – Brigham and Womens Hospital
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    2:26 PM - 2:45 PM EST
    Panel Discussion | Our Understanding on the Pathophysiology and Mechanism of Atherosclerosis and the New Therapeutic Options
    Location: Monroe
    Moderator: Takashi Akasaka, MD, PhD – Nishinomiya Watanabe Cardiovascular Cerebral Center
    Moderator: Rasha Al-Lamee, MA, MD, PhD – Imperial College London
    Moderator: Renu Virmani, MD – CVPath Institute, Inc.
    Panel Discussant: Usman Baber, MD, MS – University of Oklahoma Health Sciences Center
    Panel Discussant: Charles German, MD, MS, FAHA, FASPC – Georgetown University
    Panel Discussant: Ramzi Khamis, MB ChB PhD FRCP FESC – Imperial College London and Imperial College Healthcare NHS Trust
    Panel Discussant: Seth S. Martin, MD, MHS, FACC, FAHA, FASPC – Johns Hopkins
    Panel Discussant: Paul M. Ridker, MD – Brigham and Womens Hospital
    Panel Discussant: Robert S. Rosenson, MD – Mount Sinai Health System
    Panel Discussant: Allen J. Taylor, MD – MedStar Heart and Vascular Institute
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    2:45 PM - 2:53 PM EST
    Phenotyping Plaque and Physiology With CCTA
    Location: Monroe
    Speaker: Jonathon Leipsic, MD, FRCPC – St. Paul's Hospital
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    2:45 PM - 3:41 PM EST
    ADVANCES IN IMAGING OF THE ATHEROSCLEROTIC PLAQUE
    Location: Monroe
    Moderator: Charles German, MD, MS, FAHA, FASPC – Georgetown University
    Moderator: Michael H. Joner, MD – Deutsches Herzzentrum Muenchen
    Moderator: Deepak Talreja, MD – Sentara/ Eastern VIrginia Medical School
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    2:53 PM - 3:01 PM EST
    OCT and Not Physiology is the Optimum Modality for Determining Whether Bystander Lesions can be Deferred – Rationale and Update on INTERCLIMA
    Location: Monroe
    Speaker: Francesco Prati – San Giovanni Hospital Rome, Italy
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    3:01 PM - 3:09 PM EST
    The Status of Vulnerable Plaque Detection and Progress of Trials of Focal Vulnerable Plaque Treatment
    Location: Monroe
    Speaker: James E. Muller, MD – Brigham and Women's Hospital
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    3:09 PM - 3:17 PM EST
    Vulnerability Post-Bypass Surgery | Insight from FAST Track CABG Trial
    Location: Monroe
    Speaker: Patrick W. Serruys, MD, PhD – University of Galway, Ireland
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    3:17 PM - 3:25 PM EST
    What are the Dangerous Vulnerable Plaques and Treatment Options | Lessons from COMBINE-INTERVENE
    Location: Monroe
    Speaker: Elvin Kedhi, MD – McGill University Health Center
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    3:25 PM - 3:33 PM EST
    Prognostic Implications of Coronary Calcification | A Sub-Analysis of the LRP Study
    Location: Monroe
    Speaker: Hector M. Garcia-Garcia, MD, PhD – MedStar Washington Hospital Center
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    3:33 PM - 3:41 PM EST
    GLP-1 Receptor Antagonists | The End of Vascular Calcification?
    Location: Monroe
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    3:41 PM - 3:49 PM EST
    Vulnerable Plaque 2025 | Where Do We Stand From the Pathologic Perspective?
    Location: Monroe
    Speaker: Aloke V. Finn, MD – CVPath
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    3:41 PM - 4:13 PM EST
    CLINICAL TRIALS TO DETECT VP FINDINGS AND INTERPRETATION
    Location: Monroe
    Moderator: Elvin Kedhi, MD – McGill University Health Center
    Moderator: Ryan D. Madder, MD – Corewell Health
    Moderator: Angela M. Taylor, MD, MS, MBA – University of Virginia
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    3:49 PM - 3:57 PM EST
    Rethinking Coronary Artery Disease | It's All about the Plaque
    Location: Monroe
    Speaker: Rasha Al-Lamee, MA, MD, PhD – Imperial College London
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    3:57 PM - 4:05 PM EST
    Which Intracoronary Imaging-Based Lesion Characteristics Should We Use for Selection of High-Risk Plaques in Need of Pre-Emptive Therapy? Lessons From Previous Clinical Trials
    Location: Monroe
    Speaker: Takashi Akasaka, MD, PhD – Nishinomiya Watanabe Cardiovascular Cerebral Center
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    4:05 PM - 4:13 PM EST
    Lipid Management After PVI | Should We Manage PAD Patients Differently Then CAD Patients?
    Location: Monroe
    Speaker: Schuyler Jones, MD – Duke University Health System
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    4:13 PM - 4:21 PM EST
    Therapy for Prevention of Myocardial Infarction
    Location: Monroe
    Speaker: Jean-Claude Tardif, MD – Montreal Heart Institute
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    4:13 PM - 5:35 PM EST
    ATHEROSCLEROSIS THERAPEUTIC OPTIONS AND MANAGEMENT | WHATS NEXT
    Location: Monroe
    Moderator: Charles German, MD, MS, FAHA, FASPC – Georgetown University
    Moderator: Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI – Icahn School of Medicine at Mount Sinai, New York
    Moderator: Jean-Claude Tardif, MD – Montreal Heart Institute
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    4:21 PM - 4:29 PM EST
    Target Populations for Novel Triglyceride Lowering Therapies
    Location: Monroe
    Speaker: Robert S. Rosenson, MD – Mount Sinai Health System
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    4:29 PM - 4:37 PM EST
    The Role of Lp(a) and Lipidomics in Plaque Development From PROSPECT II
    Location: Monroe
    Speaker: David Erlinge, MD, PhD – Lund University
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    4:37 PM - 4:45 PM EST
    Antiinflammatory Agents on the Horizon for Secondary Prevention in ACS Patients
    Location: Monroe
    Speaker: Paul A. Gurbel, MD, FSCAI – Sinai Center for Thrombosis Research and Drug Development
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    4:45 PM - 4:53 PM EST
    DNA Damage and Repair in Patients with Stable Angina
    Location: Monroe
    Speaker: Michael Mahmoudi, MD – University Hospital Southampton NHS FT
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    4:51 PM - 4:59 PM EST
    The CARUSO Trial
    Location: Monroe
    Speaker: Tiziana Claudia Aranzulla, MD, MSc – A.O. Ordine Mauriziano di Torino
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    4:59 PM - 5:07 PM EST
    ACS Pharma Trials on the Horizon | LDL Lowering Therapies
    Location: Monroe
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    5:07 PM - 5:15 PM EST
    Evolving Lipid Therapies Pharmacogenetics-Based Dalcetrapib Therapy for Prevention of Myocardial Infarction
    Location: Monroe
    Speaker: Scott W. Shurmur, MD – Texas Tech Health Sciences Center, Lubbock
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    5:15 PM - 5:35 PM EST
    Panel Discussion | Atherosclerosis Therapeutic Options and Management - What is Promising?
    Location: Monroe
    Moderator: Charles German, MD, MS, FAHA, FASPC – Georgetown University
    Moderator: Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI – Icahn School of Medicine at Mount Sinai, New York
    Moderator: Jean-Claude Tardif, MD – Montreal Heart Institute
    Panel Discussant: Tiziana Claudia Aranzulla, MD, MSc – A.O. Ordine Mauriziano di Torino
    Panel Discussant: Marc P. Bonaca, MD
    Panel Discussant: David Erlinge, MD, PhD – Lund University
    Panel Discussant: Paul A. Gurbel, MD, FSCAI – Sinai Center for Thrombosis Research and Drug Development
    Panel Discussant: Michael Mahmoudi, MD – University Hospital Southampton NHS FT
    Panel Discussant: Robert S. Rosenson, MD – Mount Sinai Health System
    Panel Discussant: Scott W. Shurmur, MD – Texas Tech Health Sciences Center, Lubbock
    Panel Discussant: Ori Waksman, MD – Medstar Washington Hospital Center
    Atherosclerosis and Lipids
  • Sunday, Mar 8th
    5:35 PM EST
    Adjourn
    Location: Monroe
    Atherosclerosis and Lipids